Gene therapy for cancer

This publication has 129 references indexed in Scilit:

• Enhancement of the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Bystander Effect and Its Antitumor Efficacy In Vivo by Pharmacologic Manipulation of Gap Junctions
  Human Gene Therapy, 1998
• Adenovirus Vectors as Transcomplementing Templates for the Production of Replication Defective Retroviral Vectors
  Biochemical and Biophysical Research Communications, 1998
• Regional Suppression of Tumor Growth byIn VivoTransfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of theflt-1Vascular Endothelial Growth Factor Receptor
  Human Gene Therapy, 1998
• Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies
  JNCI Journal of the National Cancer Institute, 1998
• Antiviral immunity
  Immunology Today, 1997
• Adenovirus-Mediated Gene Transfer of Herpes Simplex Virus Thymidine Kinase in an Ascites Model of Human Breast Cancer
  Human Gene Therapy, 1996
• Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Breast Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas
  Human Gene Therapy, 1996
• Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
  European Journal Of Cancer, 1995
• Targeted Eradication of Ovarian Cancer Mediated by Intracellular Expression of Anti-erbB-2 Single-Chain Antibody
  Gynecologic Oncology, 1995
• Replicating vectors for gene therapy of cancer: risks, limitations and prospects
  European Journal Of Cancer, 1994